59
Participants
Start Date
January 22, 2019
Primary Completion Date
July 29, 2020
Study Completion Date
July 29, 2020
JUVÉDERM®
Facial filler injection (JUVÉDERM VOLBELLA with Lidocaine, and/or JUVÉDERM VOLIFT with Lidocaine, and/or JUVÉDERM VOLUMA with Lidocaine, and/or JUVÉDERM VOLITE with Lidocaine) from Month 6 to Month 8 (BELKYRA Treatment) and Month 0 to Month 2 (Non-BELKYRA Treatment).
BOTOX Cosmetic®
BOTOX Cosmetic, 20 U to glabellar lines and/or 2-6 U injected bilaterally to crow's feet lines and/or 24 U injected to forehead lines at Month 9 and Month 10 (BELKYRA Treatment) and at Month 3 and Month 4 (Non-BELKYRA Treatment).
BELKYRA®
BELKYRA, subcutaneous injection for maximum of 6 treatments, 1 month apart from Month 0 to Month 5. Maximum dose = 100 mg (10mL).
SkinMedica
SkinMedica products (Facial Cleanser, TNS Essential Serum®, Rejuvenative Moisturizer, Optional: Total Defense + Repair Broad Spectrum Sunscreen SPF34), applied daily from Month 6 to Month 11 (BELKYRA Treatment) and Month 0 to Month 5 (Non-BELKYRA Treatment).
Carruthers & Humphrey Cosmetic Dermatology, Vancouver
Shannon Humphrey, Vancouver
Project Skin MD Vancouver, Vancouver
Pacific Derm, Vancouver
Dermetics, Burlington
Dr Nowell Solish, Toronto
Bertucci MedSpa, Woodbridge
Lead Sponsor
Allergan
INDUSTRY